Commercial Scale Production Of Rare Cannabinoids Is Finally Possible

Synthetic biology company Demetrix has discovered it is more economical and socially responsible to make cannabinoids through fermentation. Now the company is scaling up with a new partnership.

Read the full post at Forbes - Healthcare
Vote This Post DownVote This Post Up (No Ratings Yet)
Explore the Archive